Latest News & Features
Americas
Cancer Research UK has announced a new research collaboration aimed at discovering new technologies to enable the early detection of cancer. 24 October 2019
Americas
Former Holland & Knight trial lawyer Merri Moken has joined Paul Hastings’ team in New York as of counsel. 24 October 2019
Americas
Choosing the right IP strategy is crucial for companies, but constrained budgets and picking the wrong partners are all factors that can steer companies off the correct path. 24 October 2019
Big Pharma
US biotechnology company 10x Genomics is to pay its competitor, Becton Dickinson, $25 million as part of a deal to end worldwide patent infringement litigation between the companies. 23 October 2019
Big Pharma
The special 25th anniversary BIO-Europe 2019 global life science partnering event will be held November 11–13, 2019, in Hamburg, Germany. 22 October 2019
Americas
The Annual Summit on Life Sciences IP Due Diligence to be held on November 14 and 15 in Boston, MA, is a one-of-a-kind, interactive forum where diligence experts discuss best practices and strategies for executing a proper IP due diligence analysis for incumbent portfolios and those of potential targets. 22 October 2019
Americas
A joint venture between gene-editing startup CRISPR Therapeutics and German pharmaceutical company Bayer will come under the control of CRISPR Therapeutics, according to the pair’s proposed plans. 22 October 2019
Americas
While the next Alice or Mayo is unlikely to be handed down next year, there are many slightly less “revolutionary" developments likely to crop up in 2020, according to Charles Larsen, partner at White & Case. 22 October 2019
Big Pharma
The US House Committee on Energy & Commerce has voted to advance a drug pricing plan which would lower the cost of many prescription drugs. 21 October 2019
Americas
The US Food and Drug Administration has announced record approvals of generic drugs in 2019, amid growing pressure over drug prices in the US. 21 October 2019